{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:04:08Z","timestamp":1784657048684,"version":"3.55.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients awaiting heart transplantation (HT) frequently require prolonged continuous dobutamine infusion. Whether oral beta-blocker (BB) therapy should be maintained during this period remains controversial and poorly studied, particularly in the context of prolonged concomitant use. The impact of BB continuation on waiting-list outcomes in this specific scenario is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective single-centre cohort study including adult patients listed for HT who received\u2009\u2265\u200930 consecutive days of concomitant oral BB therapy and continuous intravenous dobutamine between January 2020 and December 2023. The index date was defined as the first day after completion of this 30-day period, identifying patients who had already demonstrated sustained haemodynamic tolerance to the combination. Patients were classified according to BB continuation or suspension after the index date. Competing-risk analyses were performed using inverse probability of treatment weighting (IPTW), Aalen\u2013Johansen cumulative incidence functions, and Fine\u2013Gray regression. Robustness was assessed through nonparametric bootstrapping (1,500 replications).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 53 eligible patients (mean age 50.8\u2009\u00b1\u200911.9 years; 64% male), 29 underwent HT and 16 died before transplantation. After IPTW adjustment, BB continuation was associated with a higher cumulative incidence of HT at \u2265 270 days (61.1% vs 14.3%; p\u2009&lt;\u20090.001) and a lower cumulative incidence of pre-transplant death (13.3% vs 68.7%; p\u2009&lt;\u20090.001). Fine\u2013Gray regression confirmed these associations: HT sHR 8.79 (95% bootstrap CI 2.66\u201354.31) and pre-transplant mortality sHR 0.077 (95% bootstrap CI 0.014\u20130.192). Results were consistent across four pre-specified sensitivity analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study evaluates outcomes in patients sustaining oral beta-blocker therapy during prolonged dobutamine infusion while awaiting heart transplantation, a clinical scenario with limited available data. BB continuation was associated with a higher probability of transplantation, with consistent direction across pre-specified sensitivity analyses. Given the small sample size and the potential for residual confounding by indication, these findings should be interpreted with caution and are best viewed as hypothesis-generating. They may help inform future research, particularly prospective studies in this setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0354128","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:24:31Z","timestamp":1784654671000},"page":"e0354128","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Continuation of beta-blockers during prolonged dobutamine infusion in heart transplant\u2013prioritised patients: A competing-risk analysis"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5959-9359","authenticated-orcid":true,"given":"Joao Manoel","family":"Rossi Neto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7061-0238","authenticated-orcid":true,"given":"Victor Bemfica","family":"de Mello Mattos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airton Salviano Sousa","family":"Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Aurelio","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael Machado","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plinio Jose Whitaker","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Bonasso","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Potsch Camara Mattos","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Casadei","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"pone.0354128.ref001","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.healun.2021.07.015","article-title":"The International Thoracic Organ Transplant Registry of the ISHLT: Thirty-eighth adult heart transplantation report\u20132021","volume":"40","author":"KK Khush","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"pone.0354128.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 ISHLT listing criteria for heart transplantation: a 10-year update","volume":"35","author":"MR Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"pone.0354128.ref003","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the HFA of the ESC","volume":"20","author":"MG Crespo-Leiro","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"pone.0354128.ref004","first-page":"403","article-title":"Inotropes and Arrhythmias: Are We Doing Harm or Guilt by Association?","volume":"39","author":"S Christie","year":"2023","journal-title":"Can J Cardiol"},{"issue":"6","key":"pone.0354128.ref005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.08.003","article-title":"Chronic inotropic therapy in end-stage heart failure","volume":"152","author":"PJ Hauptman","year":"2006","journal-title":"Am Heart J"},{"issue":"2","key":"pone.0354128.ref006","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0002-9343(80)90387-3","article-title":"Tolerance to dobutamine after a 72 hour continuous infusion","volume":"69","author":"DA Unverferth","year":"1980","journal-title":"Am J Med"},{"issue":"4","key":"pone.0354128.ref007","first-page":"64","article-title":"The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock","volume":"10","author":"R Ryu","year":"2022","journal-title":"Med Sci (Basel)"},{"key":"pone.0354128.ref008","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ejhf.39","article-title":"Weaning from inotropic and concomitant beta-blocker therapy in severely ill heart failure patients","volume":"16","author":"AA Constantinescu","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"pone.0354128.ref009","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cardfail.2022.03.352","article-title":"Beta-blockers and Ambulatory Inotropic Therapy","volume":"28","author":"R Zaghlol","year":"2022","journal-title":"J Card Fail"},{"issue":"4","key":"pone.0354128.ref010","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2018.01.491","article-title":"Intravenous Inotropes, Beta Blockers and Survival in Ambulatory Heart Failure Patients - A Contemporary Analysis of 3,311 Patients","volume":"37","author":"O Havakuk","year":"2018","journal-title":"The Journal of Heart and Lung Transplantation"},{"key":"pone.0354128.ref011","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks","volume":"18","author":"TA Gooley","year":"1999","journal-title":"Stat Med"},{"key":"pone.0354128.ref012","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"JP Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"pone.0354128.ref013","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: possibilities and pitfalls","volume":"41","author":"PK Andersen","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"1","key":"pone.0354128.ref014","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ejhf.956","article-title":"Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: a nationwide Spanish registry","volume":"20","author":"E Barge-Caballero","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"pone.0354128.ref015","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.athoracsur.2021.09.079","article-title":"Competing Risks to Transplant in Bridging With Continuous-flow Left Ventricular Assist Devices","volume":"114","author":"NH Bakir","year":"2022","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"pone.0354128.ref016","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/EDE.0b013e3181bd5638","article-title":"Concerning the consistency assumption in causal inference","volume":"20","author":"TJ VanderWeele","year":"2009","journal-title":"Epidemiology"},{"issue":"4","key":"pone.0354128.ref017","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeae054","article-title":"Beta-blocker initiation under dobutamine infusion in acute advanced heart failure: a target trial emulation with observational data","volume":"4","author":"Y Mori","year":"2024","journal-title":"Eur Heart J Open"},{"issue":"3","key":"pone.0354128.ref018","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/EDE.0000000000000457","article-title":"Sensitivity Analysis Without Assumptions","volume":"27","author":"P Ding","year":"2016","journal-title":"Epidemiology"},{"key":"pone.0354128.ref019","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.healun.2024.05.010","article-title":"ISHLT guidelines for the evaluation and care of cardiac transplant candidates \u2013 2024","volume":"43","author":"Y Peled","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"pone.0354128.ref020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"79","author":"PA Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"pone.0354128.ref021","first-page":"1212","article-title":"Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation","volume":"14","author":"J Kalman","year":"1995","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"pone.0354128.ref022","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1053-2498(00)00201-1","article-title":"Experience with beta-blocker therapy in patients with advanced heart failure evaluated for HTx","volume":"19","author":"R Berger","year":"2000","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"pone.0354128.ref023","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1053-2498(02)01225-1","article-title":"Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers","volume":"22","author":"LR Peterson","year":"2003","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"pone.0354128.ref024","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1074248414559838","article-title":"Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit","volume":"20","author":"JC Jentzer","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"3","key":"pone.0354128.ref025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0033-0620(98)80056-X","article-title":"Parenteral inotropic support for advanced congestive heart failure","volume":"41","author":"CV Leier","year":"1998","journal-title":"Prog Cardiovasc Dis"},{"issue":"12","key":"pone.0354128.ref026","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"P Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:24:36Z","timestamp":1784654676000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354128"}},"subtitle":[],"editor":[{"given":"Moises","family":"Auron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0354128","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}